A key biomarker in this field is C-reactive protein (CRP), a prototypical marker of systemic inflammation, which not only plays a contributory role in the pathophysiology of CAD but also holds significant clinical interest as a marker for disease assessment and prognosis [11,12]. This evidence concerns the gene CRP and coronary artery disorder.